Among the four endometrial cancer (EC) TCGA molecular groups, the MSI/hypermutated group represents an important percentage of tumors (30%), including different histotypes, and generally confers an intermediate prognosis for affected women, also providing new immunotherapeutic strategies. Immunohistochemistry for MMR proteins (MLH1, MSH2, MSH6 and PMS2) has become the optimal diagnostic MSI surrogate worldwide. This review aims to provide state-of-the-art knowledge on MMR deficiency/MSI in EC and to clarify the pathological assessment, interpretation pitfalls and reporting of MMR status.

Addante, F., D'Amati, A., Santoro, A., Angelico, G., Inzani, F., Arciuolo, D., Travaglino, A., Raffone, A., D'Alessandris, N., Scaglione, G., Valente, M., Tinnirello, G., Sfregola, S., Padial Urtueta, B., Piermattei, A., Cianfrini, F., Mulè, A., Bragantini, E., Zannoni, G. F., Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications, <<INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES>>, 2024; 25 (2): 1056-1062. [doi:10.3390/ijms25021056] [https://hdl.handle.net/10807/271422]

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications

Santoro, Angela
;
Inzani, Frediano;Arciuolo, Damiano;D'Alessandris, Nicoletta;Valente, Michele;Piermattei, Angelo;Zannoni, Gian Franco
2024

Abstract

Among the four endometrial cancer (EC) TCGA molecular groups, the MSI/hypermutated group represents an important percentage of tumors (30%), including different histotypes, and generally confers an intermediate prognosis for affected women, also providing new immunotherapeutic strategies. Immunohistochemistry for MMR proteins (MLH1, MSH2, MSH6 and PMS2) has become the optimal diagnostic MSI surrogate worldwide. This review aims to provide state-of-the-art knowledge on MMR deficiency/MSI in EC and to clarify the pathological assessment, interpretation pitfalls and reporting of MMR status.
2024
Inglese
Addante, F., D'Amati, A., Santoro, A., Angelico, G., Inzani, F., Arciuolo, D., Travaglino, A., Raffone, A., D'Alessandris, N., Scaglione, G., Valente, M., Tinnirello, G., Sfregola, S., Padial Urtueta, B., Piermattei, A., Cianfrini, F., Mulè, A., Bragantini, E., Zannoni, G. F., Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications, <<INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES>>, 2024; 25 (2): 1056-1062. [doi:10.3390/ijms25021056] [https://hdl.handle.net/10807/271422]
File in questo prodotto:
File Dimensione Formato  
ijms-25-01056.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 3.18 MB
Formato Adobe PDF
3.18 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/271422
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact